Navigation Links
Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
Date:6/5/2013

HAYWARD, Calif., June 5, 2013 /PRNewswire/ -- Rafael Simon, a veteran in the environment and energy industries, has joined Microvi Biotechnologies as Chairman of its Board of Directors. Rafael was the COO of Zenon Environmental, a leading water treatment company, previous to its acquisition by GE Water in 2006 for nearly $700 M.

(Photo: http://photos.prnewswire.com/prnh/20130605/PH26398 )

While at Zenon, Rafael was responsible for all aspects of sales, operations, R&D and manufacturing. During his tenure at Zenon, share price tripled and he was named Canada's top COO by Canadian Business, Canada's leading business magazine.

"Rafael brings expertise in strategy and a depth of knowledge in our market focus that will be important in Microvi's continuing commercialization of its MicroNiche Engineering Platform Technology," said Dr. Fatemeh Shirazi , CEO of Microvi. "I am delighted to welcome him as Chairman of Microvi's Board of Directors."

He joins Microvi at a pivotal growth period, building on successful scaling and commercialization of the company's platform technology and various biocatalytic solutions for clean water, renewable biofuels, biochemicals and other industrial bioprocesses.

"I'm excited to have the opportunity to help scale-up the revolutionary Microvi biocatalyst technology which has the potential to disrupt so many industries," said Rafael.

Previous to his work with Zenon, Rafael worked at McKinsey & Company specializing in corporate growth strategies for water and energy companies.  Rafael currently serves as director on a number of boards internationally and received his Ph.D. in Materials Science and Mineral Engineering from the University of California, Berkeley.

About Microvi

Microvi is a leading biotechnology company that discovers, develops, manufactures, and commercializes innovative biocatalytic technologies in water, energy and chemical industries. Microvi's pipeline of solutions, created using its proprietary MicroNiche Engineering™ platform, enable cost-effective economics, are energy efficient and waste free and deliver higher performance than conventional methods. To learn more please visit www.microvi.com.

Media Contact:

Karin Kidder , Microvi Biotechnologies, 1-510-344-0668
Email

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Microvi
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Microvi and Aquatech Break Ground on Large Demonstration System at Aerojet Site in Rancho Cordova, CA
2. Dr. Gerald Jerry Zon Launches New Blog for TriLink BioTechnologies
3. TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S, Copenhagen, Denmark
4. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
5. TriLink BioTechnologies Awards Keck Science Department ResearchReward
6. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
7. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
8. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
9. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
10. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
11. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... ... (NYS DFS) cybersecurity regulations have transitioned into full force and effect. The ... the state (“Covered Entities”) to conduct an annual, professional, comprehensive cybersecurity risk ...
(Date:9/18/2017)... ... September 18, 2017 , ... ... move of the SPIE Digital Library ( http://www.spiedigitallibrary.org ) on 15 August to ... an improved user experience and incorporate a number of enhancements and new features, ...
(Date:9/17/2017)... ... , ... GeneOne Life Science, Inc. announces that it has ... for an Investigational New Drug application for a Phase I/IIa study of its ... in Korea represents the second clinical trial for GLS-5300. , A US ...
(Date:9/14/2017)... and London UK (PRWEB) , ... September 14, ... ... gather the most innovative minds in pharma and biotech at the third annual ... two-day collaborative conference that brings together the world’s most progressive clinical research leaders ...
Breaking Biology Technology:
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
Breaking Biology News(10 mins):